ESR1 and breast cancer: [39], encompassing 26 breast cancer primary tumors of diverse subtypes by hormonal status (estrogen receptor [ER], progesterone receptor [PR] status), Her2 signaling status (Her2 amplification/deletion), and molecular PAM50 subtyping [39].